Matt has extensive experience leading strategic engagements supporting business development and commercialization strategy. Matt has broad experience across all major therapeutic areas with a particular focus on oncology. His clients span biotech, mid-size pharma, and large pharma, and his expertise includes new product planning strategy, portfolio prioritization, therapeutic area and corporate growth strategy, and business development / licensing support. He also works with many life sciences investors conducting due diligences on both therapeutics and life sciences services businesses.
Matt has 10+ years of experience in life-sciences-related consulting. Prior to joining ClearView, Matt worked as a Senior Consultant at IMS Consulting Group in New York and in Investor Relations for IQVIA. Prior to that, he worked provider consulting with MedAssets. He received an MBA from the Northwestern’s Kellogg School of Management and a B.S. in biomedical engineering from Vanderbilt University.
Debbi Amanti Belanger
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Dean Griffiths
Kim Goh
Slater Hurst
Ketan Kapadia
Philip Kenner
Jessica Lee
Stuart MacGregor
Charles Mathews
David McClain
Kai-Ming Pu
Richard Mynahan
Kevin Richard
Derek Riesenberg
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Michael Agne
Jonathan Betts
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Dave Konciak
Alexander Lehrman
Matthew Pfister
Olivia Piccione
Sarah Stapleton
Brian Quinn
Kelsey Yardumian
Jake Arakal
Kali Barnes
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Joanna Lee
Angela Liu
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Shachi Patel
Cem Salfati
Sam Smith
Jim Duffy
Lainey Miller
Melanie Robinson